Literature DB >> 16969502

Androgen receptor negatively influences the expression of chemokine receptors (CXCR4, CCR1) and ligand-mediated migration in prostate cancer DU-145.

Takuya Akashi1, Keiichi Koizumi, Osamu Nagakawa, Hideki Fuse, Ikuo Saiki.   

Abstract

We previously reported that androgen receptor (AR) plays a role in the regulation of adhesion to the extracellular matrix and invasion of human prostate cancer cells by influencing the expression of specific integrin subunits. It is now considered that chemokines play a significant role in organ-selective cancer metastasis. In this study, we hypothesized that AR may influence the expression of these chemokine receptors and cell function. The mRNA expression of chemokine receptors in human prostate cancer cell line DU-145 and DU-145 cells expressing AR (DU-145/AR) was investigated by RT-PCR. DU-145 cells selectively expressed CXCR4 and CCR1 mRNA at high levels compared with DU-145/AR cells. DU-145 showed vigorous migratory responses to its ligand CXCL12 (also called stromal-derived factor-1alpha, SDF-1alpha) and CCL3 (also called macrophage inflammatory protein-1, MIP-1alpha). In contrast, neither CXCL12 nor CCL3 affected the migration of DU-145/AR cells. These results indicate that expression of AR down-regulates the migratory responses of human prostate cancer cells via chemokine and its receptor systems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969502

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

Review 1.  Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.

Authors:  Guilhem Roubaud; Bobby C Liaw; William K Oh; David J Mulholland
Journal:  Nat Rev Clin Oncol       Date:  2016-11-22       Impact factor: 66.675

2.  Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells.

Authors:  Juan Cai; Pridvi Kandagatla; Rajareddy Singareddy; Anthony Kropinski; Shijie Sheng; Michael L Cher; Sreenivasa R Chinni
Journal:  Transl Oncol       Date:  2010-06-01       Impact factor: 4.243

Review 3.  The chemokine receptors CXCR4 and CXCR3 in cancer.

Authors:  Amy M Fulton
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

4.  Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy.

Authors:  David L Blum; Tatsuki Koyama; Amosy E M'Koma; Juan M Iturregui; Magaly Martinez-Ferrer; Consolate Uwamariya; Joseph A Smith; Peter E Clark; Neil A Bhowmick
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

5.  Paracrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer Cells.

Authors:  Eileen L Heinrich; Amanda K Arrington; Michelle E Ko; Carrie Luu; Wendy Lee; Jianming Lu; Joseph Kim
Journal:  Cancer Microenviron       Date:  2013-02-01

Review 6.  The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer.

Authors:  Sheng-Qiang Yu; Kuo-Pao Lai; Shu-Jie Xia; Hong-Chiang Chang; Chawnshang Chang; Shuyuan Yeh
Journal:  Asian J Androl       Date:  2008-12-22       Impact factor: 3.285

7.  Gene network and canonical pathway analysis in prostate cancer: a microarray study.

Authors:  Hakan Savli; Attila Szendröi; Imre Romics; Balint Nagy
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

Review 8.  Chemokines and chemokine receptors as promoters of prostate cancer growth and progression.

Authors:  Nicole Salazar; Miguel Castellan; Samir S Shirodkar; Bal L Lokeshwar
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2013       Impact factor: 1.807

9.  The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

Authors:  A Popple; L G Durrant; I Spendlove; P Rolland; I V Scott; S Deen; J M Ramage
Journal:  Br J Cancer       Date:  2012-03-13       Impact factor: 7.640

10.  WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma.

Authors:  Bing-Qi Li; Shuai Huang; Qian-Qian Shao; Jian Sun; Li Zhou; Lei You; Tai-Ping Zhang; Quan Liao; Jun-Chao Guo; Yu-Pei Zhao
Journal:  Oncol Lett       Date:  2017-02-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.